Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martina Panebianco
Observed name:
M. Panebianco
Institution:
Azienda Ospedaliera San Giovanni Addolorata
Observed institutions:
Università Cattolica del Sacro Cuore,
Azienda Ospedaliera San Giovanni Addolorata,
Agostino Gemelli University Polyclinic,
ASL Roma,
Azienda Ospedaliera Sant'Andrea,
Istituti di Ricovero e Cura a Carattere Scientifico,
Sapienza University of Rome
show all 7
ORCID:
0000-0001-7686-5973
Observed ORCID:
0000-0001-7686-5973
OpenAlex ID:
A5069360178
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents
2019
·
Alessandro Rossi
, Michela Roberto
, et al.
·
European Journal of Pharmacology
·
99
PDF
Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
2021
·
Michela Roberto
, Andrea Botticelli
, et al.
·
Frontiers in Oncology
·
39
PDF
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach
2022
·
Francesca Matilde Schipilliti
, Maurizio Onorato
, et al.
·
Radiology and Oncology
·
30
PDF
Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach
2021
·
Michela Roberto
, Alessandro Rossi
, et al.
·
Pharmaceuticals
·
16
PDF
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management
2023
·
Michela Roberto
, Martina Panebianco
, et al.
·
Frontiers in Oncology
·
15
PDF
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer
2021
·
Marta Piras
, Martina Panebianco
, et al.
·
Current Oncology
·
14
PDF
Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin’s lymphoma
2018
·
Martina Panebianco
, Oreste Bagni
, et al.
·
Leukemia Research
·
12
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study
2022
·
Michela Roberto
, Giulia Arrivi
, et al.
·
Cancer Management and Research
·
11
PDF
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice?
2024
·
Martina Panebianco
, Chiara Ciccarese
, et al.
·
Cancers
·
5
PDF
An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report)
2021
·
Martina Panebianco
, Beatrice Taurelli Salimbeni
, et al.
·
Current Oncology
·
4
PDF
The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent axitinib (axi).
2025
·
Chiara Ciccarese
, Antonio Agostini
, et al.
·
Journal of Clinical Oncology
·
3
PDF
Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trials
2024
·
Martina Panebianco
, Vittore Cereda
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
3
2023 ASCO genitourinary cancers symposium: focus on renal cell carcinoma
2023
·
Annunziato Anghelone
, Alessandro Strusi
, et al.
·
Expert Review of Anticancer Therapy
·
3
2023 ASCO Genitourinary Cancers Symposium: a focus on urothelial carcinoma
2023
·
Antonio Cigliola
, Viria Beccia
, et al.
·
Expert Review of Anticancer Therapy
·
2
Evaluation of PBRM1, PD-L1, CD31, and CD4/CD8 ratio as a predictive signature of response to VEGFR-TKI–based therapy in patients with metastatic renal cell carcinoma (mRCC) with IMDC intermediate prognosis: Results from the APAChE-I Study.
2023
·
Chiara Ciccarese
, Sebastiano Buti
, et al.
·
Journal of Clinical Oncology
·
2
P-124 Tumor budding and CDX2 as additional prognostic factors in stage II colon cancer
2020
·
M. Roberto
, D. Ierinò
, et al.
·
Annals of Oncology
·
1
Impact of immunotherapy in patients with upper tract urothelial carcinoma: a meta-analysis of randomized trials
2026
·
Denis Occhipinti
, CHIARA CICCARESE
, et al.
·
SSRN Electronic Journal
PDF
Multidisciplinary Approach In Advanced Perivascular Epithelioid Cell Tumour (PEComa): A Case Report
2021
·
Martina Panebianco
, Debora Ierinò
, et al.
·
Archives of Clinical and Medical Case Reports
29P The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC)
2020
·
G. Arrivi
, P. Marchetti
, et al.
·
Annals of Oncology
PDF
Patients with classical H odgkin lymphoma ( CHL ) and treatment failure despite a negative iPET have poor outcomes as patients with positive iPET and treatment escalation
2017
·
J.M. Zaucha
, W. Khair
, et al.
·
Hematological Oncology
PDF
Italia y el acta unica europea
1989
·
Martina Panebianco
·
Integración latinoamericana
Show more works
View as search
Works count:
21
Citation count:
259
H-index:
8
I10-index:
8
Year
Topic
Type